An increase in IL-17A ILC3 is associated with the development of inflammatory bowel disease [19], multiple sclerosis [20] and NEC [3, 4], while a decrease in this subset is associated with the development of sepsis [5]. This evidence concerns the gene IL17A and necrotizing enterocolitis.